Welcome to LookChem.com Sign In | Join Free Post buying lead Chemical Tools
Home > Products > 192391-48-3

Detail of "192391-48-3"

  • CAS Number:
  • 192391-48-3
  • Name:
  • ImmunoglobulinG2a, anti-(human CD20 (antigen)) (mouse monoclonal clone B1R1 g2a-chain),disulfide with mouse monoclonal clone B1R1 lx-chain, dimer, iodine-131I-labeled

  • Synonyms:
  • 3:PN: WO2008003319 PAGE: 45 claimed sequence; Bexxar; Iodine I131 tositumomab;Tositumab

Famous Chemical Enterprises

  • Livzon
  • Total
  • Shell
  • Dupont
  • Exxonmobil
  • Akzonobel
  • Basf
  • Bayer
  • BP
  • Business Type
  • Certificates
Please post your buying leads>>
Display:
  • Manufacturer
  • Enterprise Authentication
  • Suppiers of more reward points first
  • New supplier
Supplier of this product? Please post selling leads now!

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Reference

Recent advance in radioimmunotherapy for B-cell lymphoma
All Rights Reserved. Recent advance in radioimmunotherapy for B-cell lymphoma. 206181-63-7 and 192391-48-3 are cas registry numbers. These chemicals are also mentioned in this article. Watanabe, Takashi (Hematology Division, National Cancer Center Hospital, Tokyo 104-0045, Japan). Ketsueki, Shuyoka, 52(4), 377-381 (Japanese) 2006 Kagaku Hyoronsha. CODEN: KETSBI. ISSN: 0915-8529. DOCUMENT TYPE: Journal; General Review CA Section: 8 (Radiation Biochemistry) Section cross-reference(s): 15 A review, discussing recent advance in radioimmunotherapy for B-cell lymphoma with radioactive tositumomab (Bexxar) and ibritunomab (Zevalin). .
Please post your buying leads
so that our qualified suppliers will soon contact you!

©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

[Hangzhou]86-571-85317600,85317603,85317620